The Nigerian Government has said Dolutegravir (DTG), the new drug for the treatment of HIV/AIDS, is already being used in Nigeria, although only by those who can afford it because of its high cost.
DTG can improve and prolong the lives of people who suffer side effect and resistance to other treatments and is the drug of choice for people with HIV in high-income countries who have never taken anti-retroviral therapy before and for those who have developed resistance to other treatments.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article